|
Jubilant
strengthens hold in US through Trinity
Jubilant Organosys’ recent acquisition of US-based Trinity
Laboratories Inc and Trigen Laboratories Inc will be a long term
strategy for the Indian drug maker to achieve a stronghold in the
US and other regulated markets.
Biocon’s
cancer molecule enters phase II-B clinical trials
Biocon’s head and neck cancer drug molecule TheraCIM (hr3)—developed
in association with the Cuban firm CMAB—has entered into phase
II-B clinical trials.
Noble
Fiber scouts for strategic partners in India
As part of its plan to enhance its presence in the Asian region,
US-based Noble Fibre Technologies Inc is scouting for strategic
partnership with leading medical companies in India to manufacture
and market its product X-static here.
Ranbaxy
to market JB Chemicals’ Doktor Mom Herbal brand range in Romania
Ranbaxy Laboratories Limited will market JB Chemicals & Pharmaceuticals’
key herbal range brand, Doktor Mom, in the Romanian market.
Dishman
enters into an agreement with NU SCAAN, UK
Dishman Pharmaceuticals & Chemicals Ltd has announced that the
company has entered into an agreement with a leading British company
NU SCAAN, for the development and manufacture of bulk actives for
nutraceutical products.
‘Pharma
units not meeting manufacturing norms face risk of closure’
The Maharashtra Food and Drug Administration has threatened to cancel
licenses of around 200 pharmaceutical units in the state which do
not comply with Good Manufacturing Practices (GMP) required under
Schedule M norms of the Drugs and Cosmetics Act.
Vivimed
Labs entering capital market with IPO of 25 lakh shares
Vivimed Labs Ltd, a Karnataka-based company, is entering the capital
market with a public issue of 25 lakh equity shares of Rs 10 each
for cash at a premium of Rs 60 per share aggregating Rs 17.50 crore
to part finance its proposed expansion project.
Zydus
to supply free medicines in flood hit areas
Domestic pharma major Cadila Healthcare said it would supply medicines
free of cost in the flood-affected areas of Gujarat.
US
FDA inspects Lupin’s Goa plant
Domestic pharma company Lupin Ltd’s plans to enter the regulated
markets got a shot in the arm with the company’s plant in Verma,
Goa, being inspected by the United States Food and Drug Administration
(US FDA).
|
